Oxford Asset Management’s Esperion Therapeutics ESPR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $74.9K | Buy |
+27,330
| New | +$86.5K | 0.03% | 424 |
|
|
2025
Q4 | – | Sell |
-46,270
| Closed | -$123K | – | 569 |
|
|
2025
Q3 | $123K | Buy |
+46,270
| New | +$89.5K | 0.04% | 398 |
|
|
2024
Q3 | – | Sell |
-42,161
| Closed | -$93.6K | – | 348 |
|
|
2024
Q2 | $93.6K | Buy |
+42,161
| New | +$99.2K | 0.09% | 242 |
|
|
2020
Q1 | – | Sell |
-17,182
| Closed | -$1.02M | – | 569 |
|
|
2019
Q4 | $1.02M | Sell |
17,182
-31,170
| -64% | -$1.4M | 0.03% | 849 |
|
|
2019
Q3 | $1.77M | Buy |
48,352
+737
| +2% | +$29.2K | 0.04% | 620 |
|
|
2019
Q2 | $2.21M | Buy |
+47,615
| New | +$2.24M | 0.05% | 599 |
|
|
2019
Q1 | – | Sell |
-23,472
| Closed | -$1.08M | – | 1743 |
|
|
2018
Q4 | $1.08M | Buy |
23,472
+12,676
| +117% | +$611K | 0.03% | 831 |
|
|
2018
Q3 | $485K | Buy |
+10,796
| New | +$496K | 0.01% | 1321 |
|
|
2018
Q2 | – | Sell |
-11,046
| Closed | -$799K | – | 1762 |
|
|
2018
Q1 | $799K | Buy |
+11,046
| New | +$811K | 0.02% | 1044 |
|
|
2017
Q4 | – | Sell |
-14,309
| Closed | -$715K | – | 1673 |
|
|
2017
Q3 | $715K | Buy |
+14,309
| New | +$690K | 0.01% | 1083 |
|
|
2017
Q2 | – | Sell |
-25,211
| Closed | -$890K | – | 1530 |
|
|
2017
Q1 | $890K | Sell |
25,211
-4,440
| -15% | -$102K | 0.02% | 854 |
|
|
2016
Q4 | $371K | Sell |
29,651
-36,290
| -55% | -$432K | 0.01% | 633 |
|
|
2016
Q3 | $913K | Sell |
65,941
-171,002
| -72% | -$1.94M | 0.03% | 532 |
|
|
2016
Q2 | $2.34M | Sell |
236,943
-43,399
| -15% | -$719K | 0.08% | 338 |
|
|
2016
Q1 | $4.74M | Buy |
280,342
+125,265
| +81% | +$2.02M | 0.14% | 172 |
|
|
2015
Q4 | $3.53M | Buy |
+155,077
| New | +$3.91M | 0.08% | 269 |
|
Other funds holding ESPR
WA
TSC
O
VCM
